Evaluation of the Efficacy and Tolerability of Nebivolol versus Lisinopril in the Treatment of Essential Arterial Hypertension: A Randomized, Multicentre, Double-blind Study

By AGABITI ROSEI ENRICO   RIZZONI DAMIANO   COMINI SILVIA   BOARI GIANLUCA  

Blood Pressure, Vol. 12, Iss. 1, 2003-01 ,pp. : 30-35

Informa Healthcare

Access to resources Recommend Favorite

Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in Chinese patients with mild to moderate hypertension

By Ueng Kwo-Chang   Lin Lung-Chun   Voon Wen-Chol   Lin Ming-Cheng   Liu Yen-Bin   Su Ho-Ming   Chang Po-Yuan   Lin Tsung-Hsien   Chen Wei-Liang   Wu Chau-Chung   Lai Wen-Ter   Lin Chung-Sheng  

Blood Pressure, Vol. 17, Iss. 1, 2008-06 ,pp. : 24-31

Informa Healthcare

Access to resources Recommend Favorite

Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?

By  

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 15-20

Bentham Science Publishers

Access to resources Recommend Favorite

Olmesartan for the treatment of arterial hypertension

By Schindler Christoph   Ferrario Carlos M  

Future Cardiology, Vol. 4, Iss. 4, 2008-07 ,pp. : 357-372

Future Medicine

Access to resources Recommend Favorite